Fate Therapeutics appoints Jamie Harrell senior vice president
Jamie Harrell will lead commercialization of CAR T-cell therapies and oversee market development and commercial operations.
Story updates
11:01:31 AM UTC
SquawkNews
Fate Therapeutics appointed Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to lead commercialization across autoimmunity and oncology programs, including FT819 in a Phase 2 trial for refractory lupus nephritis.Material DetailsContext by AI AnalystThis is an early…